Novartis Settles With Estate of Henrietta Lacks Over Stolen Cervical Cancer Cells
Novartis has reached a settlement with the estate of Henrietta Lacks over the use of the HeLa cell line, a line of human cells derived from tissue removed from Lacks during medical treatment for cervical cancer without her knowledge or consent. Terms of the settlement were not publicly disclosed.1 The settlement resolves claims that pharmaceutical […]
Spike Protein from mRNA COVID Shots Detected in Placenta and Fetal Cells
A new peer-reviewed study has found spike protein and vaccine-derived mRNA in human placental tissue and fetal immune cells, including in mothers who were vaccinated before pregnancy and had no documented SARS-CoV-2 infection. The study, published Mar. 5, 2026 in PLOS One, analyzed 106 placentas from women who delivered between 2020 and 2022 and used […]
Upcoming ACIP Meeting to Focus on COVID-19 Shot Injuries
The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) are scheduled to meet on Mar. 18-19, 2026 to discuss the injuries to people who received COVID-19 shots and the matter of safety monitoring related to the shots, particularly with regard to the development of myocarditis (inflammation of the heart […]
Moderna’s mNEXSPIKE mRNA COVID-19 Shot Approved by European Commission
The European Commission (EC) has granted marketing authorization for Moderna’s mNEXSPIKE mRNA COVID-19 shot, allowing it to be marketed across the European Union (U.N.). The authorization follows a regulatory review and permits all 27 E.U. Member States, as well as Iceland, Liechtenstein and Norway, to consider the shot for use within their vaccination programs. It […]
“Profound Autism” Under Consideration as New Diagnosis
Autism has emerged as one of the most intensely debated public health issues over the past three decades, but especially during the past year. U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr. has vowed to launch a sweeping research initiative aimed at identifying underlying causes of autism—a move applauded by some advocates […]
Combination mRNA COVID-Influenza Shot Recommended by European Medicines Agency
The European Medicine Agency (EDA) has recommended marketing authorization for Moderna’s mCombriax mRNA (messenger ribonucleic acid) shot. The product, also known as mRNA-1083, is a genetically engineered biologic targeting both influenza and COVID-19. It builds on work Moderna has done on its next-generation mRNA COVID shot known as mNexSpike and mRNA-1010.1 2 3 The recommendation […]